Virtu Financial LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 78 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$4,000
-42.9%
10,060
-56.7%
0.00%
-100.0%
Q3 2019$7,000
-72.0%
23,252
-75.5%
0.00%0.0%
Q2 2019$25,000
-83.3%
94,842
+266.8%
0.00%
-88.9%
Q3 2018$150,000
+163.2%
25,860
+94.6%
0.01%
+200.0%
Q2 2018$57,000
-63.7%
13,288
-53.5%
0.00%
-62.5%
Q3 2017$157,00028,5750.01%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,464,807$14,468,0005.57%
COURAGE CAPITAL MANAGEMENT LLC 192,486$1,130,0000.86%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,455$531,0000.07%
Alambic Investment Management, L.P. 86,204$506,0000.07%
Kalos Management, Inc. 30,000$164,0000.05%
Dynamic Technology Lab Private Ltd 32,394$190,0000.03%
ELLINGTON MANAGEMENT GROUP LLC 60,600$356,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 55,008$323,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$129,0000.02%
ACADIAN ASSET MANAGEMENT LLC 580,972$3,411,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders